Article Versions Notes

Shawish I, Barakat A, Aldalbahi A, Alshaer W, Daoud F, Alqudah DA, Al Zoubi M, Hatmal MM, Nafie MS, Haukka M, et al. Acetic Acid Mediated for One-Pot Synthesis of Novel Pyrazolyl s-Triazine Derivatives for the Targeted Therapy of Triple-Negative Breast Tumor Cells (MDA-MB-231) via EGFR/PI3K/AKT/mTOR Signaling Cascades. Pharmaceutics. 2022; 14(8):1558. https://doi.org/10.3390/pharmaceutics14081558

Shawish, Ihab, Assem Barakat, Ali Aldalbahi, Walhan Alshaer, Fadwa Daoud, Dana A. Alqudah, Mazhar Al Zoubi, Ma’mon M. Hatmal, Mohamed S. Nafie, Matti Haukka, and et al. 2022. "Acetic Acid Mediated for One-Pot Synthesis of Novel Pyrazolyl s-Triazine Derivatives for the Targeted Therapy of Triple-Negative Breast Tumor Cells (MDA-MB-231) via EGFR/PI3K/AKT/mTOR Signaling Cascades" Pharmaceutics 14, no. 8: 1558. https://doi.org/10.3390/pharmaceutics14081558

Shawish, I., Barakat, A., Aldalbahi, A., Alshaer, W., Daoud, F., Alqudah, D. A., Al Zoubi, M., Hatmal, M. M., Nafie, M. S., Haukka, M., Sharma, A., de la Torre, B. G., Albericio, F., & El-Faham, A. (2022). Acetic Acid Mediated for One-Pot Synthesis of Novel Pyrazolyl s-Triazine Derivatives for the Targeted Therapy of Triple-Negative Breast Tumor Cells (MDA-MB-231) via EGFR/PI3K/AKT/mTOR Signaling Cascades. Pharmaceutics, 14(8), 1558. https://doi.org/10.3390/pharmaceutics14081558